Satoru Kuroda
Direttore Tecnico/Scientifico/R&S presso Aphoenix, Inc.
Profilo
Satoru Kuroda is currently the Chief Technology Officer at Aphoenix, Inc. Prior to this, he worked as a Principal at Astellas Pharma, Inc. He received his undergraduate degree in 1986 and his doctorate degree in 1999 from Kyushu University.
Posizioni attive di Satoru Kuroda
| Società | Posizione | Inizio |
|---|---|---|
Aphoenix, Inc.
 Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Direttore Tecnico/Scientifico/R&S | 27/04/2009 |
Precedenti posizioni note di Satoru Kuroda
| Società | Posizione | Fine |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Formazione di Satoru Kuroda
| Kyushu University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aphoenix, Inc.
Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Health Services |
- Borsa valori
- Insiders
- Satoru Kuroda
